Two recent clinical trials noted that there is an increase in mitochondrial ROS production, as well as in the inflammatory enzyme myeloperoxidase (MPO), among females with PCOS, and the concentrations were even higher among those who presented with obesity and insulin resistance [13,14]. The gene discussed is MPO; the disease is polycystic ovary syndrome.